The novelty of this study is that the concentration of IL-17 in the serum of gastric cancer patients was positively correlated with VEGF, which may be involved in the development of gastric cancer through the secretion of VEGF, so IL-17 shows great potential as a new predictor of gastric cancer. The gene discussed is VEGFA; the disease is gastric cancer.